NM_014467.3:c.646G>T
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3
The NM_014467.3(SRPX2):c.646G>T(p.Gly216Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000000912 in 1,096,293 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G216S) has been classified as Likely benign.
Frequency
Consequence
NM_014467.3 missense
Scores
Clinical Significance
Conservation
Publications
- rolandic epilepsy-speech dyspraxia syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- polymicrogyria, bilateral perisylvian, X-linkedInheritance: XL Classification: LIMITED Submitted by: G2P
- rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linkedInheritance: XL Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD4 exome  AF:  9.12e-7  AC: 1AN: 1096293Hom.:  0  Cov.: 32 AF XY:  0.00  AC XY: 0AN XY: 361793 show subpopulations 
GnomAD4 genome  
ClinVar
Not reported inComputational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at